Select Your Location:
Global
France
Switzerland DE | FR | IT
Italy

memo inHaematology Special Issue Congress Report: EHA2024

Disease State: Follicular lymphoma

A global congress digest on targeted therapies in B-cell malignancies covering updates from recent studies presented at EHA2024.

Reading
26 May 2025
Please login or register to access the download

A summary of 12 studies from ASH 2024 addressing the use of BTK inhibitors, Bcl-2 inhibitors, BTK degraders, and other emerging therapies for B-cell malignancies.

Slide-Kit
26 May 2025
Please login or register to access the download

ROSEWOOD (NCT03332017) is a global Phase 2, randomized study designed to assess the efficacy and safety of zanubrutinib + obinutuzumab versus obinutuzumab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) who have received ≥2 lines of therapy.

Reading
23 May 2025